Thema: US8740602052
TAK, US8740602052
stock-exchange-1376104_1920.jpg - Foto: THN
Takeda stock: FY2026 outlook rises as pipeline advances
Takeda stock follows an upgraded FY2026 outlook and positive Phase 3 cancer results. Capital Markets Day is set for December 11.
ad-hoc-news.de, heute 10:22 Uhr
TAK, US8740602052
Takeda stock gets higher FY2026 outlook after first-half ...
Takeda stock enters a new phase after first-half results and an upgraded FY2026 outlook. New medicines are driving the company's growth plan.
ad-hoc-news.de, 30.10.26 09:41 Uhr
TAK, US8740602052
Analyst consensus raises target for Takeda stock to USD ...
Takeda reports fiscal second-quarter results on October 29. Takeda stock costs EUR 18.50 on October 27, 2026, up 2.21 percent versus the Tradegate close.
ad-hoc-news.de, 27.10.26 15:31 Uhr
TAK, US8740602052
Takeda sets October 29 results date for Takeda Pharmaceutical ...
Takeda presents fiscal 2026 second-quarter results on October 29. Fiscal 2026 guidance calls for JPY 4,640.0 billion revenue.
ad-hoc-news.de, 27.10.26 09:27 Uhr
TAK, US8740602052
14 analysts lift Takeda Pharmaceutical stock target to USD ...
Takeda will release second-quarter results on October 29, 2026. Takeda Pharmaceutical stock was USD 20.41 on October 26, up 0.84 percent.
ad-hoc-news.de, 26.10.26 16:05 Uhr
TAK, US8740602052
Takeda plans Japan filing. Takeda stock gets 10.2-month ...
Takeda plans a Japan filing after 10.2 months of median survival. Takeda stock last stood at EUR 16.80 on Tradegate on October 9, 2026.
ad-hoc-news.de, 26.10.26 09:08 Uhr
TAK, US8740602052
TAK stock has results scheduled for October 29, 2026
Takeda develops medicines and vaccines through research and development. The company has scheduled its FY2026 second-quarter information for October 29, 2026.
ad-hoc-news.de, 26.10.26 07:43 Uhr
TAK, US8740602052
Takeda reports positive cancer-study results. Takeda stock ...
Takeda reported positive Phase 3 cancer-study results on October 23. Takeda stock trades at EUR 18.00 in weekend trading on October 25.
ad-hoc-news.de, 25.10.26 17:05 Uhr
TAK, US8740602052
Takeda reports cancer trial gains as Takeda Pharmaceutical ...
Takeda Pharmaceutical stock trades at EUR 18.00 in weekend trading on October 24, 2026. Takeda reported cancer-study results on October 23.
ad-hoc-news.de, 24.10.26 10:22 Uhr
TAK, US8740602052
Takeda Pharmaceutical stock: TradingView lifts target for ...
